TrialCNS drugs2023

Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study.

Jan Lycke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.